Stemcells Inc. has beaten all my expectations. Since merging with Microbot there is a lot of cashflow running in. Investors of Microbot hold up to 75% in longer perspective so this picking still slides hihgly potential to be the next Gilead. Next target would proceed the incompleted gap close from May while it rumoured the company puts all operations. This shows the thin line between dropping to zero and big surprises in picking pennies. :))))))))))))))))))))))